(Q45885364)

17 December 2017

title

Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model (English)

1 reference

17 December 2017

0 references

0 references

1 reference

Minoru Horinaga

1

1 reference

17 December 2017

Kelley M Harsch

2

1 reference

17 December 2017

Ryuichi Fukuyama

3

1 reference

17 December 2017

Warren Heston

4

1 reference

17 December 2017

William Larchian

5

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

17 December 2017

published in

Urology

1 reference

17 December 2017

volume

66

1 reference

17 December 2017

page(s)

461-466

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Biology and management of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

The potential role of gene therapy in the treatment of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Non-antibody immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

BCG immunotherapy of bladder cancer: 20 years on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

A cancer gene therapy approach through translational control of a suicide gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Antitumor activity of interleukin-12 against murine bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Interleukin-12. Opportunities for the treatment of bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

A triploblast origin for Myxozoa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.03.052

10.1016/J.UROLOGY.2005.03.052

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

16040105

1 reference

17 December 2017